Tandem Diabetes Care Inc (NASDAQ: TNDM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Citigroup Inc. from $57.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
- Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in CanadaBusiness Wire
- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock.MarketBeat
- Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own [Seeking Alpha]Seeking Alpha
TNDM
Earnings
- 11/6/24 - Beat
TNDM
Sec Filings
- 12/18/24 - Form 4
- 12/18/24 - Form 4
- 11/22/24 - Form 4
- TNDM's page on the SEC website